acf/google-ad-placement

Never miss a trade again with the fastest news alerts in the world!
 This headline only article is a sample of real-time intelligence
 <a href="https://benzinga.grsm.io/headlineonlyarticles3398">Benzinga Pro</a> traders use to win in the markets everyday.
 Want the fastest, most accurate stock market intelligence? Want EXCLUSIVE stories originated by Benzinga reporters?
 <a href="https://benzinga.grsm.io/headlineonlyarticles3398">Join 10,000+ serious traders in the Benzinga Pro community!</a>

Biotech

News

General

Ocean Biomedical's Anti-CHI3L1 patent coverage includes multiple methods of use for targeting a broad range of Cancers that include Lung Cancer, Glioblastoma, Prostate Cancer, Melanoma, and Breast Cancer&nbsp;Providence,

Ocean Biomedical Announces Publication Of New Data Deepening Understanding Of Novel Cancer Immunotherapy Treatment Approach Targeting CHI3L1 And Its Ability To Inhibit Anti-Tumor And Related Tissue Remodeling Responses - Ocean Biomedical (NASDAQ:OCEA)

Benzinga Newsdesk

Ocean Biomedical

OCEA

Ocean Biomedical Announces Publication Of New Data Deepening Understanding Of Novel Cancer Immunotherapy Treatment Approach Targeting CHI3L1 And Its Ability To Inhibit Anti-Tumor And Related Tissue Remodeling Responses

Comments